Anatomical segmentectomy has been developed to offer better pulmonary function
preservation than lobectomy, in stage IA lung cancer. Despite the retrospective nature of …

Over the past decade, targeted therapy for oncogene-driven NSCLC and immune
checkpoint inhibitors for non-oncogene-driven NSCLC, respectively, have greatly improved …

NSCLC is common and is the primary cause of cancer-related deaths due to a lack of early
diagnosis and its propensity for metastasis. The pathogenesis of NSCLC is still unclear …

Non‐small cell lung cancer (NSCLC) accounts for approximately one in five cancer‐related
deaths, and management requires increasingly complex decision making by health care …

Background The standard for clinical staging of lung cancer is the use of CT and PET scans,
however, these may underestimate the burden of the disease. The use of serum tumor …

Non-small cell lung cancer (NSCLC) remains the most common cause of cancer-related
mortality. The heterogeneous nature of this disease hinders its diagnosis and treatment …

STAT3 is an oncogenic transcription factor that regulates the expression of genes which are
involved in malignant transformation. Aberrant activation of STAT3 has been observed in a …

Background Treatment outcomes of advanced non-small cell lung cancer (NSCLC) have
substantially improved with immune checkpoint inhibitors (ICI), although only approximately …

Purpose To provide guidance on quality improvement thresholds for outcomes and
complications of image-guided thermal ablation for the treatment of early stage non-small …

Introduction There is controversy regarding the clinical T (cT) category of lung
adenocarcinomas that manifest as part-solid nodules (PSNs). We aimed to validate the cT …